Cargando…
754例Ⅰ期-Ⅲa期可手术切除非小细胞肺癌患者EGFR和KRAS基因突变状态及其临床意义
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR) and KRAS gene are important driver genes of non-small cell lung cancer (NSCLC). The studies are mainly focused on detection of EGFR gene for advanced NSCLC, and the mutation feature of EGFR and KRAS gene in early NSCLC tissue is unkno...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973370/ https://www.ncbi.nlm.nih.gov/pubmed/28935015 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.09.05 |
Ejemplares similares
-
EGFR突变状态对可手术切除的肺腺癌患者复发及生存的预测价值
Publicado: (2013) -
可切除Ⅲa/N2期非小细胞肺癌治疗模式探讨
Publicado: (2019) -
121例手术切除的N2-Ⅲa期非小细胞肺癌患者的生存分析
Publicado: (2015) -
手术切除的N2期非小细胞肺癌预后影响因素探究
Publicado: (2020) -
非小细胞肺癌的BRAF基因突变及其临床意义
Publicado: (2012)